Fig. 5From: A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancerAlterations in the immune cell infiltration discriminated by the M6A-related lncRNA-based risk model are associated with GC riskBack to article page